Find
Helping Moms and Children
Johnson & Johnson has a long history of focusing on saving and improving the lives of women and children, building the skills of people who serve community health needs and preventing disease. In September 2010, the Company announced a comprehensive, five-year, private-sector effort to improve the health of women and children in developing countries. The initiative supports the United Nations’ April 2010 call for a renewed effort to achieve the Millennium Development Goals of reducing mortality in women and children.
Since its launch last September, Johnson & Johnson has laid a strong foundation for measurable impact in several areas toward Every Woman, Every Child, the United Nations’ Global Strategy for Women’s and Children’s Health to reduce mortality in women and children by 2015, including: expanding health information for mothers over mobile phones, helping to increase the number of safe births, doubling donations of treatments for intestinal worms in children, helping to ensure that no child is born with HIV, and furthering research and development of new medicines for HIV and tuberculosis (TB).
Read the Johnson & Johnson news release on the strong progress the Company has made in the first year of this initiative.
As part of the United Nation’s Every Woman, Every Child Campaign, we have committed to improve the health of as many as 120 million women and children each year in developing countries by 2015 through a number of programs:
- Mobile Alliance for Maternal Action (MAMA): Health information over existing mobile phones for pregnant women and new moms
- Children Without Worms (CWW): Treatments and education for intestinal worms
- Helping Babies Breathe (HBB): Efforts to enhance birth safety and the health of newborn babies.
- Health 4+ Partnership: Efforts to train skilled birth attendants, in a partnership with the Health4+ joint United Nations Program
- One Million Health Workers Challenge: Training and support for front-line health workers including skilled birth attendants in the developing world.
See below for more information:
Mobile Health for Mothers
With more than 1.1 billion women in low- and moderate-income countries owning a mobile phone, it is now possible to provide timely health information in even the most remote locations. Fact Sheet: Empowering Mothers with Health Information through Mobile Technology |
|
Intestinal Worms in Children
Johnson & Johnson more than doubled its donation of mebendazole, a treatment for intestinal worms in children, through its Children Without Worms program, up from 36 million doses in 2010 to 80 million doses by the end of 2011. The Company plans to continue to expand this program to distribute 200 million doses each year by 2015. |
|
R&D Innovations
We are committed the ongoing research & development of new medicines to treat tuberculosis (TB) and HIV, both of which affect women and children in the developing world. Fact Sheet: R&D for the Developing World |
|
Safe Birth Programs
We will extend current commitments to peer education programs that have been successful in preventing mother-to-child transmission of HIV; reducing a life-threatening condition in infants cause by lack of oxygen at birth (birth asphyxia); and upgrading existing health care facilities to accommodate more women at risk of fistulas, a debilitating tissue rupture in mothers caused by obstructed labor, resulting in incontinence and infections. Infographic: Midwives Save Lives |
|
New Commitments to Prevent Non-Communicable Diseases
Beyond our enduring commitment to women’s and children’s health, Johnson & Johnson is building alliances in prevention, aligning with the United Nations Secretary General’s call-to-action to address the major causes of chronic, non-communicable diseases globally. The Company will announce new efforts to combat smoking and tobacco use via mobile phones and workplace interventions.
|
|